Literature DB >> 10502130

A practical approach to proteinuria.

J M Bergstein1.   

Abstract

Proteinuria is defined as urinary protein excretion exceeding 150 mg/day. It may result from nonpathological (posture, fever, exercise) or pathological (glomerular or tubular) processes. Glomerular proteinuria is an early sign of kidney disease and may also play a role in the progression of glomerular damage. Asymptomatic proteinuria is common; it may be transient or persistent. Transient proteinuria is a benign condition and requires no evaluation. Persistent proteinuria can be the first sign of kidney disease. Persistent proteinuria commonly results from disorders associated with increased glomerular permeability such as nephrotic syndrome, glomerulonephritis (e.g., post-infectious, membranous, membranoproliferative, lupus, IgA), and genetic defects (Alport syndrome, mesangial sclerosis). Tubular disorders should also be considered. Evaluation for the underlying cause is traditional. Whether the early detection and evaluation of proteinuria prevents progressive disease is unknown.

Entities:  

Mesh:

Year:  1999        PMID: 10502130     DOI: 10.1007/s004670050684

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  8 in total

1.  The nephrotoxicity risk in rats subjected to heavy muscle activity.

Authors:  Gülsen Oner; Selma Cirrik
Journal:  J Sports Sci Med       Date:  2009-09-01       Impact factor: 2.988

2.  Levels of urinary transforming growth factor beta-1 in children with D+ hemolytic uremic syndrome.

Authors:  María Gracia Caletti; Alejandro Balestracci; Adriana Haydeé Roy
Journal:  Pediatr Nephrol       Date:  2010-02-16       Impact factor: 3.714

3.  Trace Proteinuria and the Incidence of Overt Proteinuria After Five Years: Results of the Kanagawa Investigation of the Total Checkup Data From the National Database-5 (KITCHEN-5).

Authors:  Kei Nakajima; Ryoko Higuchi; Kaori Mizusawa
Journal:  J Clin Med Res       Date:  2020-08-15

Review 4.  Efficacy and safety of angiotensin II receptor type 1 antagonists in children and adolescents.

Authors:  Siegtraut Dorothea Herder; Ernst Weber; Almuth Winkemann; Christoph Herder; Hartmut Morck
Journal:  Pediatr Nephrol       Date:  2010-05       Impact factor: 3.714

Review 5.  Isolated asymptomatic proteinuria.

Authors:  R N Srivastava
Journal:  Indian J Pediatr       Date:  2002-12       Impact factor: 1.967

6.  Quantification of proteinuria with urinary protein to osmolality ratios in children with and without renal insufficiency.

Authors:  Nakisa Hooman; Hassan Otoukesh; Hamid Safaii; Mitra Mehrazma; Yousefi Shokrolah
Journal:  Ann Saudi Med       Date:  2005 May-Jun       Impact factor: 1.526

7.  A misprocessed form of Apolipoprotein A-I is specifically associated with recurrent Focal Segmental Glomerulosclerosis.

Authors:  Conxita Jacobs-Cachá; Natàlia Puig-Gay; Dominic Helm; Mandy Rettel; Joana Sellarès; Anna Meseguer; Mikhail M Savitski; Francesc J Moreso; Maria José Soler; Daniel Seron; Joan Lopez-Hellin
Journal:  Sci Rep       Date:  2020-01-24       Impact factor: 4.379

8.  Association between proteinuria trajectories and outcomes in critically ill patients with sepsis or shock.

Authors:  Raphael Monge; Charlotte Oris; Matthieu Jabaudon; Marina Braïlova; Emmanuel Futier; Vincent Sapin; Bruno Pereira; Alexandre Lautrette
Journal:  PLoS One       Date:  2022-08-24       Impact factor: 3.752

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.